Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain
Clinical trial NCT06747728 · RECRUITING
Trial details
- NCT number
- NCT06747728
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.